⌘K

Aprea Therapeutics, Inc. (APRE)

$2.92 2.10% $0.06 Healthcare

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

Market cap

$15.86M

CEO

Dr. Oren Gilad Ph.D.

Full time employees

16.00

Headquarters

Boston, MA

IPO Date

Oct 03, 2019

Price-to-earnings (PE) Ratio

-0.97

Earnings-per-share (EPS)

$-3.01

Cash ratio (TTM)

9.27

Current ratio (TTM)

9.55

Net profit margin (TTM)

-1,013.41%

PE ratio (TTM)

-1.38

PEG ratio (TTM)

-0.01

Price-to-book ratio (TTM)

0.67

Price-to-sales ratio (TTM)

12.82

Quick ratio (TTM)

9.55

Return on assets (TTM)

-43.14%

Return on equity (TTM)

-54.06%

Similar stocks (15)

AnaptysBio, Inc.

ANAB

$37.53 2.63% $0.96

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$7.59 0.40% $0.03

Neutral

Generation Bio Co.

GBIO

$2.86 10.42% $0.27

Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

Armata Pharmaceuticals, Inc.

ARMP

$2.23 6.19% $0.13

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.08 4.00% $0.08

Downtrend

Unicycive Therapeutics, Inc.

UNCY

$0.43 9.53% $0.04

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Lumos Pharma, Inc.

LUMO

$3.92 5.95% $0.22

Neutral

Surrozen, Inc.

SRZN

$8.15 1.75% $0.14

Downtrend

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

Forte Biosciences, Inc.

FBRX

$7.00 4.09% $0.28

Downtrend

Silo Pharma, Inc.

SILO

$1.06 3.92% $0.04

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.16 10.00% $0.02

Downtrend

ETF Exposure (7)

Dimensional U.S. Targeted Value ETF

DFAT

1.66e-4%

$55.91 2.01% $1.10

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

4.58e-6%

$34.14 1.82% $0.61

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Downtrend

Similar stocks (15)

AnaptysBio, Inc.

ANAB

$37.53 2.63% $0.96

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$7.59 0.40% $0.03

Neutral

Generation Bio Co.

GBIO

$2.86 10.42% $0.27

Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

Armata Pharmaceuticals, Inc.

ARMP

$2.23 6.19% $0.13

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.08 4.00% $0.08

Downtrend

Unicycive Therapeutics, Inc.

UNCY

$0.43 9.53% $0.04

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Lumos Pharma, Inc.

LUMO

$3.92 5.95% $0.22

Neutral

Surrozen, Inc.

SRZN

$8.15 1.75% $0.14

Downtrend

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

Forte Biosciences, Inc.

FBRX

$7.00 4.09% $0.28

Downtrend

Silo Pharma, Inc.

SILO

$1.06 3.92% $0.04

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.16 10.00% $0.02

Downtrend

ETF Exposure (7)

Dimensional U.S. Targeted Value ETF

DFAT

1.66e-4%

$55.91 2.01% $1.10

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

4.58e-6%

$34.14 1.82% $0.61

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend